11 / 84
LatestNews
Precise technique tracks dopamine in the brain
MIT researchers have devised a way to measure dopamine in
the brain much more precisely than previously possible, which
should allow scientists to gain insight into dopamine’s roles in
learning, memory, and emotion.
Dopamine is one of the many neurotransmitters that neurons in
the brain use to communicate with each other. Previous systems
for measuring these neurotransmitters have been limited in how
long they provide accurate readings and how much of the brain
they can cover. The new MIT device, an array of tiny carbon
electrodes, overcomes both of those obstacles.
“Nobody has really measured neurotransmitter behavior at this
spatial scale and timescale. Having a tool like this will allow us
to explore potentially any neurotransmitter-related disease,” says
can
eliminate
u n n e c e s s a r y
development costs, reduce
time to market and achieve
even faster returns on
their investments,” said
Karsten Ries, CEO of
Develco Products. “As a
result, manufacturers can
focus on optimizing the
features and functionality
of their IoT products rather
than spending time and
money trying to master
the complexities of IoT
technologies.”
“Develco Products is one of the leading gateway
providers in Europe, with unparalleled experience and
number of deployed gateways across significant vertical
markets,” said David Friedman, CEO and co-founder of
Ayla Networks. “Using Ayla-supported Develco Products
gateways, manufacturers can leverage the combined Ayla
IoT software and Develco Products IoT hardware expertise
to launch reliable, secure and scalable connected products
much more easily and cost-effectively.”
IoT Gateways Boost Device Efficiency, Flexibility and
Scalability
IoT gateways provide an important alternative to installing
Michael Cima, the David H. Koch Professor of Engineering in the
Department of Materials Science and Engineering, a member of
MIT’s Koch Institute for Integrative Cancer Research, and the
senior author of the study.
Furthermore, because the array is so tiny, it has the potential to
eventually be adapted for use in humans, to monitor whether
therapies aimed at boosting dopamine levels are succeeding.
Many human brain disorders, most notably Parkinson’s disease,
are linked to dysregulation of dopamine.
“Right now deep brain stimulation is being used to treat
Parkinson’s disease, and we assume that that stimulation is
somehow resupplying the brain with dopamine, but no one’s
really measured that,” says Helen Schwerdt, a Koch
Wi-Fi or other wireless
network protocols directly
into each end-point IoT
product. Gateways enable
multiple small, low-cost
or battery-powered IoT
devices or sensors to use
the gateway hardware
technology to establish
and control their wireless
connection.
Both the Ayla and Develco
Products IoT technologies
are highly flexible and
scalable. The Ayla IoT
cloud fully integrates cloud-to-cloud services, including
leading voice control services, and serves manufacturers
globally through its cloud services in Europe, North America
and China. Able to scale efficiently from tens to millions
of devices, the Ayla-powered Develco Products gateway
architecture can also adapt to future IoT technology
requirements, as they arise.
Because the Ayla IoT cloud uses the Amazon Web
Services (AWS) cloud infrastructure, connected products
leveraging Ayla-powered Develco Products IoT gateways
will run on AWS and automatically benefit from the cloud
infrastructure’s high availability, strong security and global
reach.
New-Tech Magazine Europe l 11